Grouped by vaccine type
Vaccines in clinical trial phase
The vaccine testing process
PRECLINICAL TESTING: Vaccine is administered to animals to see if it produces an immune response.
PHASE I SAFETY TRIALS: Vaccine is adminstered to a small number of people to test safety and dosage as well as to confirm that it stimulates the immune system.
PHASE II EXPANDED TRIALS: Vaccine is given to hundreds of people split into groups such as children and the elderly to see if the vaccine acts differently in them. These trials further test the vaccine’s safety and ability to stimulate the immune system.
PHASE III EFFICACY TRIALS: Vaccine is given to thousands of people and wait to see how many become infected compared with volunteers who received a placebo. These trials can determine if the vaccine protects against the coronavirus.
Vaccines in clinical trial phase
Vaccine type
Examples of licensed human vaccines using this approach
Filter
Grouped by vaccine type
Select
Select
Select
Source of data
Table of vaccine candidates from WHO (link)Download cleaned table with vaccines in pre-clinical phase
Download cleaned table with vaccines in clinical phase
Usefull links
Contact
pkrisz5@elte.hu